ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Coronavirus Treatment Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-37M4166
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Coronavirus Treatment Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Coronavirus Treatment Drugs Market Research Report 2025

Code: QYRE-Auto-37M4166
Report
July 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Serum Institute of India
Pfizer Inc
Astrazeneca plc
Bharat Biotech International Limited
Cadila Healthcare Limited
Johnson & Johnson
Moderna, Inc
GlaxoSmithKline PLC
CanSino Biologics
SINOVAC BIOTECH
Novavax Inc
Glenmark Pharmaceuticals Limited
Dr. Reddy’s Laboratories
Merck& Co. Inc
Roche
Gilead Sciences
Eli Lilly and Company
Celltrion Healthcare
Sorrento Therapeutics

Coronavirus Treatment Drugs Market Size

The global market for Coronavirus Treatment Drugs was valued at US$ 35610 million in the year 2024 and is projected to reach a revised size of US$ 54540 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Coronavirus Treatment Drugs Market

Coronavirus Treatment Drugs Market

The coronavirus (COVID-19) is an infectious disease caused by the novel coronavirus. Those affected by COVID-19 are likely to experience mild to moderate respiratory illness and recover without requiring special treatment, but people in the age group of 50 years and above, and those and suffering from other health disorders such as hypertension, diabetes, and kidney failure are at a severe risk of infection and require specific treatment. Moreover, currently there is no medication for treating the coronavirus, and health physicians are suggesting corticosteroids, anti-viral therapies for individuals with severe symptoms.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Coronavirus Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronavirus Treatment Drugs.
The Coronavirus Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Coronavirus Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coronavirus Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Coronavirus Treatment Drugs Market Report

Report Metric Details
Report Name Coronavirus Treatment Drugs Market
Accounted market size in year US$ 35610 million
Forecasted market size in 2031 US$ 54540 million
CAGR 6.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Serum Institute of India, Pfizer Inc, AstraZeneca Plc, Bharat Biotech International Limited, Cadila Healthcare Limited, Johnson & Johnson, Moderna, GlaxoSmithKline Plc, CanSino Biologics, Sinovac Biotech, Novavax, Inc, Glenmark Pharmaceuticals Limited, Dr. Reddy's Laboratories, Merck & Co., Inc, Roche, Gilead Sciences, Eli Lilly and Company, Celltrion Healthcare, Sorrento Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Coronavirus Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Coronavirus Treatment Drugs Market growing?

Ans: The Coronavirus Treatment Drugs Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Coronavirus Treatment Drugs Market size in 2031?

Ans: The Coronavirus Treatment Drugs Market size in 2031 will be US$ 54540 million.

Who are the main players in the Coronavirus Treatment Drugs Market report?

Ans: The main players in the Coronavirus Treatment Drugs Market are Serum Institute of India, Pfizer Inc, AstraZeneca Plc, Bharat Biotech International Limited, Cadila Healthcare Limited, Johnson & Johnson, Moderna, GlaxoSmithKline Plc, CanSino Biologics, Sinovac Biotech, Novavax, Inc, Glenmark Pharmaceuticals Limited, Dr. Reddy's Laboratories, Merck & Co., Inc, Roche, Gilead Sciences, Eli Lilly and Company, Celltrion Healthcare, Sorrento Therapeutics

What are the Application segmentation covered in the Coronavirus Treatment Drugs Market report?

Ans: The Applications covered in the Coronavirus Treatment Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Coronavirus Treatment Drugs Market report?

Ans: The Types covered in the Coronavirus Treatment Drugs Market report are Corticosteroids, Anti-viral, Monoclonal Antibodies, Kinase Inhibitors, Others

Recommended Reports

COVID-19 Therapeutics

COVID-19 Vaccines

COVID-19 Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Coronavirus Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Corticosteroids
1.2.3 Anti-viral
1.2.4 Monoclonal Antibodies
1.2.5 Kinase Inhibitors
1.2.6 Others
1.3 Market by Application
1.3.1 Global Coronavirus Treatment Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Coronavirus Treatment Drugs Market Perspective (2020-2031)
2.2 Global Coronavirus Treatment Drugs Growth Trends by Region
2.2.1 Global Coronavirus Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Coronavirus Treatment Drugs Historic Market Size by Region (2020-2025)
2.2.3 Coronavirus Treatment Drugs Forecasted Market Size by Region (2026-2031)
2.3 Coronavirus Treatment Drugs Market Dynamics
2.3.1 Coronavirus Treatment Drugs Industry Trends
2.3.2 Coronavirus Treatment Drugs Market Drivers
2.3.3 Coronavirus Treatment Drugs Market Challenges
2.3.4 Coronavirus Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Coronavirus Treatment Drugs Players by Revenue
3.1.1 Global Top Coronavirus Treatment Drugs Players by Revenue (2020-2025)
3.1.2 Global Coronavirus Treatment Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Coronavirus Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Coronavirus Treatment Drugs Revenue
3.4 Global Coronavirus Treatment Drugs Market Concentration Ratio
3.4.1 Global Coronavirus Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Coronavirus Treatment Drugs Revenue in 2024
3.5 Global Key Players of Coronavirus Treatment Drugs Head office and Area Served
3.6 Global Key Players of Coronavirus Treatment Drugs, Product and Application
3.7 Global Key Players of Coronavirus Treatment Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Coronavirus Treatment Drugs Breakdown Data by Type
4.1 Global Coronavirus Treatment Drugs Historic Market Size by Type (2020-2025)
4.2 Global Coronavirus Treatment Drugs Forecasted Market Size by Type (2026-2031)
5 Coronavirus Treatment Drugs Breakdown Data by Application
5.1 Global Coronavirus Treatment Drugs Historic Market Size by Application (2020-2025)
5.2 Global Coronavirus Treatment Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Coronavirus Treatment Drugs Market Size (2020-2031)
6.2 North America Coronavirus Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Coronavirus Treatment Drugs Market Size by Country (2020-2025)
6.4 North America Coronavirus Treatment Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Coronavirus Treatment Drugs Market Size (2020-2031)
7.2 Europe Coronavirus Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Coronavirus Treatment Drugs Market Size by Country (2020-2025)
7.4 Europe Coronavirus Treatment Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Coronavirus Treatment Drugs Market Size (2020-2031)
8.2 Asia-Pacific Coronavirus Treatment Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Coronavirus Treatment Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Coronavirus Treatment Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Coronavirus Treatment Drugs Market Size (2020-2031)
9.2 Latin America Coronavirus Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Coronavirus Treatment Drugs Market Size by Country (2020-2025)
9.4 Latin America Coronavirus Treatment Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Coronavirus Treatment Drugs Market Size (2020-2031)
10.2 Middle East & Africa Coronavirus Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Serum Institute of India
11.1.1 Serum Institute of India Company Details
11.1.2 Serum Institute of India Business Overview
11.1.3 Serum Institute of India Coronavirus Treatment Drugs Introduction
11.1.4 Serum Institute of India Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.1.5 Serum Institute of India Recent Development
11.2 Pfizer Inc
11.2.1 Pfizer Inc Company Details
11.2.2 Pfizer Inc Business Overview
11.2.3 Pfizer Inc Coronavirus Treatment Drugs Introduction
11.2.4 Pfizer Inc Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.2.5 Pfizer Inc Recent Development
11.3 AstraZeneca Plc
11.3.1 AstraZeneca Plc Company Details
11.3.2 AstraZeneca Plc Business Overview
11.3.3 AstraZeneca Plc Coronavirus Treatment Drugs Introduction
11.3.4 AstraZeneca Plc Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.3.5 AstraZeneca Plc Recent Development
11.4 Bharat Biotech International Limited
11.4.1 Bharat Biotech International Limited Company Details
11.4.2 Bharat Biotech International Limited Business Overview
11.4.3 Bharat Biotech International Limited Coronavirus Treatment Drugs Introduction
11.4.4 Bharat Biotech International Limited Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.4.5 Bharat Biotech International Limited Recent Development
11.5 Cadila Healthcare Limited
11.5.1 Cadila Healthcare Limited Company Details
11.5.2 Cadila Healthcare Limited Business Overview
11.5.3 Cadila Healthcare Limited Coronavirus Treatment Drugs Introduction
11.5.4 Cadila Healthcare Limited Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.5.5 Cadila Healthcare Limited Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Coronavirus Treatment Drugs Introduction
11.6.4 Johnson & Johnson Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.6.5 Johnson & Johnson Recent Development
11.7 Moderna
11.7.1 Moderna Company Details
11.7.2 Moderna Business Overview
11.7.3 Moderna Coronavirus Treatment Drugs Introduction
11.7.4 Moderna Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.7.5 Moderna Recent Development
11.8 GlaxoSmithKline Plc
11.8.1 GlaxoSmithKline Plc Company Details
11.8.2 GlaxoSmithKline Plc Business Overview
11.8.3 GlaxoSmithKline Plc Coronavirus Treatment Drugs Introduction
11.8.4 GlaxoSmithKline Plc Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.8.5 GlaxoSmithKline Plc Recent Development
11.9 CanSino Biologics
11.9.1 CanSino Biologics Company Details
11.9.2 CanSino Biologics Business Overview
11.9.3 CanSino Biologics Coronavirus Treatment Drugs Introduction
11.9.4 CanSino Biologics Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.9.5 CanSino Biologics Recent Development
11.10 Sinovac Biotech
11.10.1 Sinovac Biotech Company Details
11.10.2 Sinovac Biotech Business Overview
11.10.3 Sinovac Biotech Coronavirus Treatment Drugs Introduction
11.10.4 Sinovac Biotech Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.10.5 Sinovac Biotech Recent Development
11.11 Novavax, Inc
11.11.1 Novavax, Inc Company Details
11.11.2 Novavax, Inc Business Overview
11.11.3 Novavax, Inc Coronavirus Treatment Drugs Introduction
11.11.4 Novavax, Inc Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.11.5 Novavax, Inc Recent Development
11.12 Glenmark Pharmaceuticals Limited
11.12.1 Glenmark Pharmaceuticals Limited Company Details
11.12.2 Glenmark Pharmaceuticals Limited Business Overview
11.12.3 Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Introduction
11.12.4 Glenmark Pharmaceuticals Limited Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.12.5 Glenmark Pharmaceuticals Limited Recent Development
11.13 Dr. Reddy's Laboratories
11.13.1 Dr. Reddy's Laboratories Company Details
11.13.2 Dr. Reddy's Laboratories Business Overview
11.13.3 Dr. Reddy's Laboratories Coronavirus Treatment Drugs Introduction
11.13.4 Dr. Reddy's Laboratories Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.13.5 Dr. Reddy's Laboratories Recent Development
11.14 Merck & Co., Inc
11.14.1 Merck & Co., Inc Company Details
11.14.2 Merck & Co., Inc Business Overview
11.14.3 Merck & Co., Inc Coronavirus Treatment Drugs Introduction
11.14.4 Merck & Co., Inc Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.14.5 Merck & Co., Inc Recent Development
11.15 Roche
11.15.1 Roche Company Details
11.15.2 Roche Business Overview
11.15.3 Roche Coronavirus Treatment Drugs Introduction
11.15.4 Roche Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.15.5 Roche Recent Development
11.16 Gilead Sciences
11.16.1 Gilead Sciences Company Details
11.16.2 Gilead Sciences Business Overview
11.16.3 Gilead Sciences Coronavirus Treatment Drugs Introduction
11.16.4 Gilead Sciences Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.16.5 Gilead Sciences Recent Development
11.17 Eli Lilly and Company
11.17.1 Eli Lilly and Company Company Details
11.17.2 Eli Lilly and Company Business Overview
11.17.3 Eli Lilly and Company Coronavirus Treatment Drugs Introduction
11.17.4 Eli Lilly and Company Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.17.5 Eli Lilly and Company Recent Development
11.18 Celltrion Healthcare
11.18.1 Celltrion Healthcare Company Details
11.18.2 Celltrion Healthcare Business Overview
11.18.3 Celltrion Healthcare Coronavirus Treatment Drugs Introduction
11.18.4 Celltrion Healthcare Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.18.5 Celltrion Healthcare Recent Development
11.19 Sorrento Therapeutics
11.19.1 Sorrento Therapeutics Company Details
11.19.2 Sorrento Therapeutics Business Overview
11.19.3 Sorrento Therapeutics Coronavirus Treatment Drugs Introduction
11.19.4 Sorrento Therapeutics Revenue in Coronavirus Treatment Drugs Business (2020-2025)
11.19.5 Sorrento Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Serum Institute of India
Pfizer Inc
Astrazeneca plc
Bharat Biotech International Limited
Cadila Healthcare Limited
Johnson & Johnson
Moderna, Inc
GlaxoSmithKline PLC
CanSino Biologics
SINOVAC BIOTECH
Novavax Inc
Glenmark Pharmaceuticals Limited
Dr. Reddy’s Laboratories
Merck& Co. Inc
Roche
Gilead Sciences
Eli Lilly and Company
Celltrion Healthcare
Sorrento Therapeutics
List of Tables
 Table 1. Global Coronavirus Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Corticosteroids
 Table 3. Key Players of Anti-viral
 Table 4. Key Players of Monoclonal Antibodies
 Table 5. Key Players of Kinase Inhibitors
 Table 6. Key Players of Others
 Table 7. Global Coronavirus Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Coronavirus Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Coronavirus Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Coronavirus Treatment Drugs Market Share by Region (2020-2025)
 Table 11. Global Coronavirus Treatment Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Coronavirus Treatment Drugs Market Share by Region (2026-2031)
 Table 13. Coronavirus Treatment Drugs Market Trends
 Table 14. Coronavirus Treatment Drugs Market Drivers
 Table 15. Coronavirus Treatment Drugs Market Challenges
 Table 16. Coronavirus Treatment Drugs Market Restraints
 Table 17. Global Coronavirus Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Coronavirus Treatment Drugs Market Share by Players (2020-2025)
 Table 19. Global Top Coronavirus Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Treatment Drugs as of 2024)
 Table 20. Ranking of Global Top Coronavirus Treatment Drugs Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Coronavirus Treatment Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Coronavirus Treatment Drugs, Headquarters and Area Served
 Table 23. Global Key Players of Coronavirus Treatment Drugs, Product and Application
 Table 24. Global Key Players of Coronavirus Treatment Drugs, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Coronavirus Treatment Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Coronavirus Treatment Drugs Revenue Market Share by Type (2020-2025)
 Table 28. Global Coronavirus Treatment Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Coronavirus Treatment Drugs Revenue Market Share by Type (2026-2031)
 Table 30. Global Coronavirus Treatment Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Coronavirus Treatment Drugs Revenue Market Share by Application (2020-2025)
 Table 32. Global Coronavirus Treatment Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Coronavirus Treatment Drugs Revenue Market Share by Application (2026-2031)
 Table 34. North America Coronavirus Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Coronavirus Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Coronavirus Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Coronavirus Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Coronavirus Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Coronavirus Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Coronavirus Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Coronavirus Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Coronavirus Treatment Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Coronavirus Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Coronavirus Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Coronavirus Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Coronavirus Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Serum Institute of India Company Details
 Table 50. Serum Institute of India Business Overview
 Table 51. Serum Institute of India Coronavirus Treatment Drugs Product
 Table 52. Serum Institute of India Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 53. Serum Institute of India Recent Development
 Table 54. Pfizer Inc Company Details
 Table 55. Pfizer Inc Business Overview
 Table 56. Pfizer Inc Coronavirus Treatment Drugs Product
 Table 57. Pfizer Inc Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 58. Pfizer Inc Recent Development
 Table 59. AstraZeneca Plc Company Details
 Table 60. AstraZeneca Plc Business Overview
 Table 61. AstraZeneca Plc Coronavirus Treatment Drugs Product
 Table 62. AstraZeneca Plc Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 63. AstraZeneca Plc Recent Development
 Table 64. Bharat Biotech International Limited Company Details
 Table 65. Bharat Biotech International Limited Business Overview
 Table 66. Bharat Biotech International Limited Coronavirus Treatment Drugs Product
 Table 67. Bharat Biotech International Limited Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 68. Bharat Biotech International Limited Recent Development
 Table 69. Cadila Healthcare Limited Company Details
 Table 70. Cadila Healthcare Limited Business Overview
 Table 71. Cadila Healthcare Limited Coronavirus Treatment Drugs Product
 Table 72. Cadila Healthcare Limited Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 73. Cadila Healthcare Limited Recent Development
 Table 74. Johnson & Johnson Company Details
 Table 75. Johnson & Johnson Business Overview
 Table 76. Johnson & Johnson Coronavirus Treatment Drugs Product
 Table 77. Johnson & Johnson Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 78. Johnson & Johnson Recent Development
 Table 79. Moderna Company Details
 Table 80. Moderna Business Overview
 Table 81. Moderna Coronavirus Treatment Drugs Product
 Table 82. Moderna Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 83. Moderna Recent Development
 Table 84. GlaxoSmithKline Plc Company Details
 Table 85. GlaxoSmithKline Plc Business Overview
 Table 86. GlaxoSmithKline Plc Coronavirus Treatment Drugs Product
 Table 87. GlaxoSmithKline Plc Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 88. GlaxoSmithKline Plc Recent Development
 Table 89. CanSino Biologics Company Details
 Table 90. CanSino Biologics Business Overview
 Table 91. CanSino Biologics Coronavirus Treatment Drugs Product
 Table 92. CanSino Biologics Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 93. CanSino Biologics Recent Development
 Table 94. Sinovac Biotech Company Details
 Table 95. Sinovac Biotech Business Overview
 Table 96. Sinovac Biotech Coronavirus Treatment Drugs Product
 Table 97. Sinovac Biotech Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 98. Sinovac Biotech Recent Development
 Table 99. Novavax, Inc Company Details
 Table 100. Novavax, Inc Business Overview
 Table 101. Novavax, Inc Coronavirus Treatment Drugs Product
 Table 102. Novavax, Inc Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 103. Novavax, Inc Recent Development
 Table 104. Glenmark Pharmaceuticals Limited Company Details
 Table 105. Glenmark Pharmaceuticals Limited Business Overview
 Table 106. Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Product
 Table 107. Glenmark Pharmaceuticals Limited Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 108. Glenmark Pharmaceuticals Limited Recent Development
 Table 109. Dr. Reddy's Laboratories Company Details
 Table 110. Dr. Reddy's Laboratories Business Overview
 Table 111. Dr. Reddy's Laboratories Coronavirus Treatment Drugs Product
 Table 112. Dr. Reddy's Laboratories Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 113. Dr. Reddy's Laboratories Recent Development
 Table 114. Merck & Co., Inc Company Details
 Table 115. Merck & Co., Inc Business Overview
 Table 116. Merck & Co., Inc Coronavirus Treatment Drugs Product
 Table 117. Merck & Co., Inc Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 118. Merck & Co., Inc Recent Development
 Table 119. Roche Company Details
 Table 120. Roche Business Overview
 Table 121. Roche Coronavirus Treatment Drugs Product
 Table 122. Roche Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 123. Roche Recent Development
 Table 124. Gilead Sciences Company Details
 Table 125. Gilead Sciences Business Overview
 Table 126. Gilead Sciences Coronavirus Treatment Drugs Product
 Table 127. Gilead Sciences Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 128. Gilead Sciences Recent Development
 Table 129. Eli Lilly and Company Company Details
 Table 130. Eli Lilly and Company Business Overview
 Table 131. Eli Lilly and Company Coronavirus Treatment Drugs Product
 Table 132. Eli Lilly and Company Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 133. Eli Lilly and Company Recent Development
 Table 134. Celltrion Healthcare Company Details
 Table 135. Celltrion Healthcare Business Overview
 Table 136. Celltrion Healthcare Coronavirus Treatment Drugs Product
 Table 137. Celltrion Healthcare Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 138. Celltrion Healthcare Recent Development
 Table 139. Sorrento Therapeutics Company Details
 Table 140. Sorrento Therapeutics Business Overview
 Table 141. Sorrento Therapeutics Coronavirus Treatment Drugs Product
 Table 142. Sorrento Therapeutics Revenue in Coronavirus Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 143. Sorrento Therapeutics Recent Development
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources
 Table 147. Authors List of This Report


List of Figures
 Figure 1. Coronavirus Treatment Drugs Picture
 Figure 2. Global Coronavirus Treatment Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Coronavirus Treatment Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Corticosteroids Features
 Figure 5. Anti-viral Features
 Figure 6. Monoclonal Antibodies Features
 Figure 7. Kinase Inhibitors Features
 Figure 8. Others Features
 Figure 9. Global Coronavirus Treatment Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Coronavirus Treatment Drugs Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Pharmacies Case Studies
 Figure 12. Retail Pharmacies Case Studies
 Figure 13. Online Pharmacies Case Studies
 Figure 14. Coronavirus Treatment Drugs Report Years Considered
 Figure 15. Global Coronavirus Treatment Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Coronavirus Treatment Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Coronavirus Treatment Drugs Market Share by Region: 2024 VS 2031
 Figure 18. Global Coronavirus Treatment Drugs Market Share by Players in 2024
 Figure 19. Global Top Coronavirus Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Treatment Drugs as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Coronavirus Treatment Drugs Revenue in 2024
 Figure 21. North America Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Coronavirus Treatment Drugs Market Share by Country (2020-2031)
 Figure 23. United States Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Coronavirus Treatment Drugs Market Share by Country (2020-2031)
 Figure 27. Germany Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Coronavirus Treatment Drugs Market Share by Region (2020-2031)
 Figure 35. China Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Coronavirus Treatment Drugs Market Share by Country (2020-2031)
 Figure 43. Mexico Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Coronavirus Treatment Drugs Market Share by Country (2020-2031)
 Figure 47. Turkey Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Coronavirus Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Serum Institute of India Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 51. Pfizer Inc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 52. AstraZeneca Plc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 53. Bharat Biotech International Limited Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 54. Cadila Healthcare Limited Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 55. Johnson & Johnson Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 56. Moderna Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 57. GlaxoSmithKline Plc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 58. CanSino Biologics Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 59. Sinovac Biotech Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 60. Novavax, Inc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 61. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 62. Dr. Reddy's Laboratories Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 63. Merck & Co., Inc Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 64. Roche Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 65. Gilead Sciences Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 66. Eli Lilly and Company Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 67. Celltrion Healthcare Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 68. Sorrento Therapeutics Revenue Growth Rate in Coronavirus Treatment Drugs Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Coronavirus Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Coronavirus Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Treatment Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Clinical Treatment for Covid 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 Traditional Chinese Medicine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Coronavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Coronavirus COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 Vaccines Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Severe Acute Respiratory Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI to Novel Coronavirus COVID 19 and Epidemic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Coronavirus Testing Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Specific Antiviral Drugs for COVID 19 Market
Oral COVID 19 Antiviral Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Remdesivir COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global COVID 19 Medicine Market Research Report 2024
Hepatitis B Virus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Antiviral Medicines for COVID 19 Market Research Report 2024
Covid 19 Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions